157 related articles for article (PubMed ID: 23107486)
21. [Morphological changes in the liver in primary sclerosing cholangitis (a histological and electron microscopic study)].
Popova IV; Beketova TP; Severov MV; Prokhorova MV
Arkh Patol; 1993; 55(3):21-5. PubMed ID: 7944963
[TBL] [Abstract][Full Text] [Related]
22. Primary sclerosing cholangitis: MR imaging features.
Ito K; Mitchell DG; Outwater EK; Blasbalg R
AJR Am J Roentgenol; 1999 Jun; 172(6):1527-33. PubMed ID: 10350284
[TBL] [Abstract][Full Text] [Related]
23. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.
Batheja N; Suriawinata A; Saxena R; Ionescu G; Schwartz M; Thung SN
Mod Pathol; 2000 Dec; 13(12):1265-8. PubMed ID: 11144921
[TBL] [Abstract][Full Text] [Related]
24. A longitudinal study of histologic and immunohistologic changes in an experimental model of sclerosing cholangitis.
Bedossa P; Houry S; Bacci J; Martin E; Lemaigre G; Huguier M
Virchows Arch A Pathol Anat Histopathol; 1989; 414(2):165-71. PubMed ID: 2492694
[TBL] [Abstract][Full Text] [Related]
25. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
[TBL] [Abstract][Full Text] [Related]
26. Bile canalicular morphometry in arteriohepatic dysplasia.
Witzleben CL; Finegold M; Piccoli DA; Treem WR
Hepatology; 1987; 7(6):1262-6. PubMed ID: 3679090
[TBL] [Abstract][Full Text] [Related]
27. The spectrum of bile duct lesions in end-stage primary sclerosing cholangitis.
Harrison RF; Hubscher SG
Histopathology; 1991 Oct; 19(4):321-7. PubMed ID: 1937411
[TBL] [Abstract][Full Text] [Related]
28. Intrahepatic cholestasis as a canalicular motility disorder. Evidence using cytochalasin.
Phillips MJ; Oshio C; Miyairi M; Smith CR
Lab Invest; 1983 Feb; 48(2):205-11. PubMed ID: 6681643
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice.
Miethke AG; Zhang W; Simmons J; Taylor AE; Shi T; Shanmukhappa SK; Karns R; White S; Jegga AG; Lages CS; Nkinin S; Keller BT; Setchell KD
Hepatology; 2016 Feb; 63(2):512-23. PubMed ID: 26172874
[TBL] [Abstract][Full Text] [Related]
30. [The structure of the terminal portions of the biliary tract of the liver and ductular hyperplasia].
Droblenkov AV
Morfologiia; 1996; 110(5):96-100. PubMed ID: 9081614
[TBL] [Abstract][Full Text] [Related]
31. Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model.
Lyoumi S; Abitbol M; Rainteau D; Karim Z; Bernex F; Oustric V; Millot S; Lettéron P; Heming N; Guillmot L; Montagutelli X; Berdeaux G; Gouya L; Poupon R; Deybach JC; Beaumont C; Puy H
Gastroenterology; 2011 Oct; 141(4):1509-19, 1519.e1-3. PubMed ID: 21762662
[TBL] [Abstract][Full Text] [Related]
32. Primary sclerosing cholangitis. Light and electron microscopy of hepatic tissue in two cases.
Chlumská A; Chlumský J; Krtek V; Jirkovská A; Pirk F; Skála I
Pathol Res Pract; 1985 Mar; 179(4-5):487-92. PubMed ID: 4001025
[TBL] [Abstract][Full Text] [Related]
33. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
[TBL] [Abstract][Full Text] [Related]
34. Geniposide suppresses liver injury in a mouse model of DDC-induced sclerosing cholangitis.
Wen M; Liu Y; Chen R; He P; Wu F; Li R; Lin Y
Phytother Res; 2021 Jul; 35(7):3799-3811. PubMed ID: 33763888
[TBL] [Abstract][Full Text] [Related]
35. Role of cytoskeleton in canalicular contraction in cultured differentiated hepatocytes.
Kawahara H; French SW
Am J Pathol; 1990 Mar; 136(3):521-32. PubMed ID: 1690509
[TBL] [Abstract][Full Text] [Related]
36. Rapid progress of acute suppurative cholangitis to secondary sclerosing cholangitis sequentially followed-up by endoscopic retrograde cholangiography.
Tanaka Y; Koshiyama H; Nakao K; Makita Y; Kobayashi Y; Yoshida Y; Kimura M; Adachi Y
Endoscopy; 2001 Jul; 33(7):633-5. PubMed ID: 11473338
[TBL] [Abstract][Full Text] [Related]
37. Primary sclerosing cholangitis.
Zein CO; Lindor KD
Semin Gastrointest Dis; 2001 Apr; 12(2):103-12. PubMed ID: 11352117
[TBL] [Abstract][Full Text] [Related]
38. [Metastatic bile duct cancer in secondary biliary cirrhosis associated with primary sclerosing cholangitis in ulcerative colitis].
Böckmann S; Bernhardt-Huth D; Huth F; Fritsch WP
Z Gastroenterol; 1990 Jul; 28(7):363-7. PubMed ID: 2173291
[TBL] [Abstract][Full Text] [Related]
39. Phalloidin-induced alterations of bile canaliculi.
Yamamoto K; Makino Y; Itoshima T; Kobayashi T; Tsuji T
Acta Med Okayama; 1988 Aug; 42(4):207-13. PubMed ID: 3177006
[TBL] [Abstract][Full Text] [Related]
40. Ultrastructural aspects of liver injury with special reference to small bile ducts in patients with ulcerative colitis.
Mattila J; Pitkänen R; Halonen P; Matikainen M
Liver; 1992 Aug; 12(4 Pt 1):155-60. PubMed ID: 1406077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
